BAMCO INC /NY/

Position in JNJ — Johnson & Johnson

CIK 1017918 NEW YORK, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,392,932

+$893,032 QoQ

Shares Held

25,172

+11.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,431

of 4,664 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BAMCO INC /NY/ holds $189,132,430 across 5 Drug Manufacturers - General names. JNJ ranks #3 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	140,540	$168,567,906
2	AZN	Astrazeneca PLC	47,835	$9,070,472
3	JNJ	Johnson & Johnson This page	25,172	$6,392,932
4	MRK	Merck & Co., Inc.	22,000	$2,827,000
5	GILD	Gilead Sciences, Inc.	18,000	$2,274,120

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,392,932	25,172	+11.9%	Shares	Defined	2026-08-14
2026-03-31	$5,499,900	22,500	+525.0%	Shares	Defined	2026-05-15
2025-12-31	$745,020	3,600	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.